| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | paclitaxel | CCLE | pan-cancer | AAC | 0.12 | 0.02 |
| mRNA | Roscovitine | FIMM | pan-cancer | AAC | -0.38 | 0.02 |
| mRNA | GDC-0941 | GDSC1000 | pan-cancer | AAC | 0.081 | 0.02 |
| mRNA | importazole | CTRPv2 | pan-cancer | AAC | 0.086 | 0.02 |
| mRNA | Sorafenib | GDSC1000 | pan-cancer | AAC | 0.12 | 0.02 |
| mRNA | selumetinib:decitabine (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.075 | 0.03 |
| mRNA | CH5424802 | GDSC1000 | pan-cancer | AAC | 0.081 | 0.03 |
| mRNA | Bortezomib | GDSC1000 | pan-cancer | AAC | -0.11 | 0.03 |
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | 0.11 | 0.03 |
| mRNA | ML006 | CTRPv2 | pan-cancer | AAC | 0.081 | 0.03 |